Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M289Revenue $M64.2Net Margin (%)16.9Altman Z-Score12.0
Enterprise Value $M247EPS $0.8Operating Margin %28.0Piotroski F-Score6
P/E(ttm)27.2Beneish M-Score-2.5Pre-tax Margin (%)26.4Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %--Quick Ratio8.9Cash flow > EarningsY
Price/Sales4.65-y EBITDA Growth Rate %--Current Ratio9.5Lower Leverage y-yY
Price/Free Cash Flow21.9y-y EBITDA Growth Rate %-0.9ROA % (ttm)11.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)12.2Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M13.0ROIC % (ttm)26.6Gross Margin Increase y-yN

Gurus Latest Trades with SRDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SRDXMario Gabelli 2015-09-30 Reduce$21.73 - $26.21
($23.47)
$ 22.26-5%Reduce -1.74%90,548
SRDXMario Gabelli 2015-06-30 Reduce$23.34 - $27.26
($25.1)
$ 22.26-11%Reduce -21.87%92,148
SRDXMario Gabelli 2015-03-31 Reduce$21.41 - $26.53
($23.82)
$ 22.26-7%Reduce -2.03%117,948
SRDXMario Gabelli 2014-12-31 Reduce-0.01%$19.55 - $22.61
($21.21)
$ 22.265%Reduce -35.06%120,398
SRDXMario Gabelli 2014-09-30 Add0.01%$18.12 - $22.4
($19.98)
$ 22.2611%Add 41.77%185,398
SRDXMario Gabelli 2014-06-30 Add0.01%$19.85 - $23.37
($21.41)
$ 22.264%Add 292.73%130,778
SRDXJoel Greenblatt 2014-03-31 Sold Out -0.03%$22.14 - $25.79
($24.45)
$ 22.26-9%Sold Out0
SRDXMario Gabelli 2014-03-31 Add$22.14 - $25.79
($24.45)
$ 22.26-9%Add 113.23%33,300
SRDXMario Gabelli 2013-12-31 Buy $21.61 - $25.135
($23.56)
$ 22.26-6%New holding15,617
SRDXJoel Greenblatt 2013-06-30 Add0.01%$19.74 - $27.55
($25.03)
$ 22.26-11%Add 38.66%59,954
SRDXJoel Greenblatt 2012-12-31 Reduce-0.03%$17.45 - $22.03
($19.85)
$ 22.2612%Reduce -25.79%53,262
SRDXJoel Greenblatt 2012-09-30 Add0.04%$15.38 - $20.78
($18.02)
$ 22.2624%Add 60.21%71,768
SRDXMario Gabelli 2012-09-30 Sold Out -0.03%$15.38 - $20.78
($18.02)
$ 22.2624%Sold Out0
SRDXJoel Greenblatt 2012-03-31 Add0.04%$13.86 - $16.06
($13.74)
$ 22.2662%Add 200.69%44,610
SRDXJoel Greenblatt 2011-12-31 Buy 0.03%$8.86 - $14.99
($11.41)
$ 22.2695%New holding14,836
SRDXMario Gabelli 2011-03-31 Add$11.53 - $13.18
($12.28)
$ 22.2681%Add 93.72%167,468
SRDXMario Gabelli 2010-12-31 Add$8.33 - $13.11
($11.02)
$ 22.26102%Add 337.72%86,450
SRDXMario Gabelli 2010-09-30 Add$10.67 - $16.5
($13.17)
$ 22.2669%Add 22.67%19,750
SRDXMario Gabelli 2010-06-30 Reduce$16.01 - $22.03
($18.4)
$ 22.2621%Reduce -55.56%16,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRDX is held by these investors:


News about SRDX:

Articles On GuruFocus.com
SurModics Inc. Reports Operating Results (10-Q) Aug 06 2010 
SurModics Inc. Reports Operating Results (10-Q) May 07 2010 
SurModics Inc. Reports Operating Results (10-Q) Feb 05 2010 
SurModics Inc. Reports Operating Results (10-K) Dec 11 2009 
SurModics Inc. (SRDX) Senior VP & CFO Philip D Ankeny sells 5,000 Shares Oct 08 2009 
SurModics Inc. Reports Operating Results (10-Q) Aug 07 2009 
SurModics Inc. Reports Operating Results (10-Q) May 08 2009 
SurModics Inc. Reports Operating Results (10-Q) Feb 09 2009 

More From Other Websites
Edited Transcript of SRDX earnings conference call or presentation 2-May-16 9:00pm GMT May 03 2016
SurModics (SRDX) Beats Q2 Earnings & Revenues Estimates May 03 2016
SurModics posts 2Q profit May 02 2016
SurModics posts 2Q profit May 02 2016
SurModics Reports Second Quarter Fiscal 2016 Results May 02 2016
SURMODICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events,... May 02 2016
SurModics Inc Earnings Call scheduled for 5:00 pm ET today May 02 2016
4:54 pm SurModics beats by $0.11, beats on revs; raises FY16 EPS and revenue guidance May 02 2016
SurModics Reports Second Quarter Fiscal 2016 Results May 02 2016
Q2 2016 SurModics Inc Earnings Release - After Market Close May 02 2016
SurModics to Webcast Second Quarter 2016 Earnings Conference Call on May 2 Apr 28 2016
SurModics to Webcast Second Quarter 2016 Earnings Conference Call on May 2 Apr 28 2016
SURMODICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 08 2016
SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon Apr 06 2016
SurModics Announces First Patient Enrolled in IDE Study of SurVeil™ Drug-Coated Balloon Apr 06 2016
OxySure Therapeutics (OXYS) May Be Undervalued Compared to Others in Biotech Space Mar 21 2016
SURMODICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters... Feb 22 2016
SurModics to Host Virtual Shareholder Meeting on February 17 Feb 16 2016
SURMODICS INC Financials Feb 11 2016
SURMODICS INC Files SEC form 10-Q, Quarterly Report Feb 05 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)